Spanish pharmacists seek medical technology in professional development drive:
This article was originally published in Clinica
Executive Summary
Almost 2,400 pharmacists in Spain have chosen medical technology-related courses since the launch of a national professional development programme in 1997. Despite the programme's focus on pharmacological topics, such as formulation theory and side effects, 1,621 have undergone training in clinical testing and 741 have been trained on medical devices. The total equates to almost one in 10 of the 27,000 professionals who have entered the programme, according to a survey conducted by the national council of official colleges of chemists.
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.